HERBALIFE LTD. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
HERBALIFE LTD. (HLF) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $28.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-18
- HERBALIFE LTD. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2015-09-30 was -$240.80M.
- HERBALIFE LTD. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $28.70M.
- HERBALIFE LTD. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$61.10M, a 347.37% decline from fiscal 2022.
- HERBALIFE LTD. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $24.70M, a 17.06% increase from fiscal 2021.
- HERBALIFE LTD. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $21.10M, a 65.12% decline from fiscal 2020.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $28.70M 10-K · filed 2026-02-18 | ||
| 2023-12-31 | -$61.10M 10-K · filed 2025-02-19 | $61.10M 10-K · filed 2024-02-14 | |
| 2022-12-31 | $24.70M 10-K · filed 2024-02-14 | ||
| 2021-12-31 | $21.10M 10-K · filed 2024-02-14 | ||
| 2020-12-31 | $60.50M 10-K · filed 2023-02-14 | ||
| 2019-12-31 | $11.20M 10-K · filed 2022-02-23 | ||
| 2018-12-31 | $52.50M 10-K · filed 2021-02-17 | $83.50M 10-K · filed 2019-02-19 | |
| 2017-12-31 | $151.20M 10-K · filed 2020-02-18 | $184.00M 10-K · filed 2018-02-22 | |
| 2016-12-31 | -$5.90M 10-K · filed 2019-02-19 | $5.90M 10-K · filed 2017-02-23 | |
| 2015-12-31 | -$208.70M 10-K · filed 2018-02-22 | $208.70M 10-K · filed 2016-02-25 | |
| 2015-09-30 | -$240.80M 10-Q · filed 2015-11-03 | ||
| 2014-12-31 | $82.40M 10-K · filed 2017-02-23 | ||
| 2013-12-31 | $38.30M 10-K · filed 2016-02-25 | ||
| 2012-12-31 | $41.20M 10-K · filed 2015-02-26 | $1.00M 10-K · filed 2013-02-19 | |
| 2011-12-31 | $29.50M 10-K · filed 2014-02-18 | $84.10M 10-K · filed 2012-02-21 | |
| 2010-12-31 | $65.40M 10-K/A · filed 2013-12-16 | $64.60M 10-K · filed 2012-02-21 | |
| 2009-12-31 | $47.40M 10-K/A · filed 2012-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |